methyl 7-(4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamido)heptanoate | 1012058-83-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 7-(4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamido)heptanoate
• 英文别名: Methyl 7-[[4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carbonyl]amino]heptanoate
• CAS: 1012058-83-1
• 化学式: C₂₈H₂₈ClF₃N₄O₅
• 分子量: 593.002
• InChiKey: ADONIIBHRRTMRW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  41
• 可旋转键数：
  13
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  119
• 氢给体数：
  3
• 氢受体数：
  9

文献信息

• RAF KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY
  申请人：Cai Xiong

  公开号：US20080234332A1

  公开（公告）日：2008-09-25

  The present invention relates to Raf kinase inhibitors containing zinc-binding and their use in the treatment of Raf related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  本发明涉及含有结合锌的Raf激酶抑制剂及其在治疗Raf相关疾病和紊乱（如癌症）中的应用。所述衍生物还可能作为HDAC抑制剂。
• Multi-Functional Small Molecules as Anti-Proliferative Agents
  申请人：Cai Xiong

  公开号：US20080221132A1

  公开（公告）日：2008-09-11

  The present invention relates to the compositions, methods, and applications of a novel approach to selective inhibition of several cellular or molecular targets with a single small molecule. More specifically, the present invention relates to multi-functional small molecules wherein one functionality is capable of inhibiting histone deacetylases (HDAC) and the other functionality is capable of inhibiting a different cellular or molecular pathway involved in aberrant cell proliferation, differentiation or survival.

  本发明涉及一种新型选择性抑制多种细胞或分子靶点的组合物、方法和应用。更具体地说，本发明涉及多功能小分子，其中一种功能能够抑制组蛋白去乙酰化酶（HDAC），另一种功能能够抑制与异常细胞增殖、分化或存活有关的不同细胞或分子途径。
• [EN] RAF KINASE INHIBITORS CONTAINING A ZINC BINDING MOIETY<br/>[FR] INHIBITEURS DE LA RAF KINASE CONTENANT UN FRAGMENT DE LIAISON AU ZINC
  申请人：CURIS INC

  公开号：WO2008115263A2

  公开（公告）日：2008-09-25

  [EN] The present invention relates to Raf kinase inhibitors containing zinc-binding and their use in the treatment of Raf related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.
  [FR] La présente invention concerne des inhibiteurs de la Raf kinase contenant un fragment de liaison au zinc et leur utilisation dans le traitement des maladies et des troubles associés à la Raf kinase, tels que le cancer. Lesdits dérivés peuvent également contenir des inhibiteurs HDAC.